http://www.marketwatch.com/story/at-300000-a-year-sareptas-new-drug...

Great that the FDA finallly got out of the way on etiplersen..but discouraging that it will be so expensive that almost no one can afford it

Views: 235

Reply to This

Replies to This Discussion

I think it was relatively well known that almost nobody was going to be able to afford this drug out of their own pocket.  It will be insurance companies (or government in some countries) that will be paying the bill.

Reply to Discussion

RSS

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2018   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service